References
- King H, Aubert RE, Herman WH: Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414-31, 1998 https://doi.org/10.2337/diacare.21.9.1414
- Available from www.diabetes.org/diabetes-statistics/national-diabetes-fact-sheet.jsp. Accessed 18 January 2005
- American Diabetes Association: Economic costs of diabetes in the U.S. in 2002. Diabetes Care 26:917-32, 2003 https://doi.org/10.2337/diacare.26.3.917
- Available from http://kosis.nso.go.kr. Accessed 31 March, 2005
- Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL: Unconventional medicine in the United States: prevalence, costs, and patterns of use. N Engl J Med 328:246-52, 1993 https://doi.org/10.1056/NEJM199301283280406
- Alternative Medicine: Expanding medical horizons: A report to the National lnstitute of Health on alternative medical systems and practices in the United States. Washington, D. C: U.S. Government Printing Office, 1994
- Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rampay M, Kessler RC: Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 280:1569-1575, 1998 https://doi.org/10.1001/jama.280.18.1569
- Millar WJ: Use of alternative health care practitioners by Canadians. Can J Public Health 88:154-8, 1997
- Ernst E: The role of complementary and alternative medicine. Br Med J 321:1133-5, 2000 https://doi.org/10.1136/bmj.321.7269.1133
- Institute For Alternative Futures: The Future of Complementary and Alternative Approaches in US Health Care. NCMIC lnsurance Company, 1998
- Argaez-Lopez N, Wacher NH, Kumate-Rodriguez J, Cruz M, Talavera J, Rivera-Arce E, Lozoya X; DIMSS study group: The use of complementary and alternative therapies in type 2 diabetic patients in Mexico. Diabetes Care 26:2470-1, 2003 https://doi.org/10.2337/diacare.26.8.2470
- Egede LE, Ye X, Zheng D, Silverstein MD: The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Diabetes Care 25:324-9, 2002 https://doi.org/10.2337/diacare.25.2.324
- American Diabetes Association: Unproven therapies (Position Statement). Diabetes Care 27(Suppl. 1): S135, 2004 https://doi.org/10.2337/diacare.27.2007.S135
- 남문석, 김경래, 조재화, 이경미, 박현영, 이은직, 임승길, 이현철, 허갑범: 설문조사에 의한 성인 당뇨병환자의 민간요법 실태. 당뇨병 18:242-8, 1994
- Shapiro K, Gong WC: Natural products used for diabetes. J Am Pharm Assoc 42:217-6, 2002 https://doi.org/10.1331/108658002763508515
- Shane-McWhorter L: Biological complementary therapies: a focus on botanical products in diabetes. Diabetes Spectrum 14:199-208, 2001 https://doi.org/10.2337/diaspect.14.4.199
- Vuksan V, Sievenpiper JL, Koo VY, Francis T, Beljan-Zdravkovic U, Xu Z, Vidgen E: American ginseng (panax quinquefolius L) reduces postprandial glycemia in non-diabetic subjects and subjects with type 2 diabetes mellitus. Arch Intern Med 160:1009-13, 2000 https://doi.org/10.1001/archinte.160.7.1009
- Vuksan V, Starvo MP, Sievenpiper JL, Beljan-Zdravkovic U, Leiter LA, Josse RG, Xu Z: Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes. Diabetes Care 23:1221-6, 2000 https://doi.org/10.2337/diacare.23.9.1221
- Ghannam N, Kingston M, AI-Meshaal IA, Tariq M, Parman NS, Woodhouse N: The antidiabetic activity of aloes: preliminary clinical and experimental observations. Horm Res 24:288-94, 1986 https://doi.org/10.1159/000180569
- Jonas WB: Alternative medicine: learning from the past, examining the present, advancing to the future. JAMA 280:1616-8, 1998 https://doi.org/10.1001/jama.280.18.1616
- 이정권: 대체의학에 대한 의상의 태도 대한의사협회지 41:1239-42, 1998
- 식품의약품안전청: 건강기능식품공전(안), p.31-122, 2003